Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
Showing 361 - 380 results of 21,342 for search '(( significant clinical decrease ) OR ( significant decrease decrease ))', query time: 0.53s Refine Results
  1. 361
    Pre-operative versus post-operative symptoms.

    Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 362
    The Human Disharmony Loop (full) Including Inciting Factors.

    The Human Disharmony Loop (full) Including Inciting Factors. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 363
    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup>

    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup> by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 364
    Patient Demographics.

    Patient Demographics. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 365
    Pain and Function Outcomes Following PM Tenotomy.

    Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 366
    Diagnostic Criteria for Human Disharmony Loop.

    Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 367
    Normal Anatomy vs. Disharmonic Pathoanatomy.

    Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 368
    The Human Disharmony Loop (central).

    The Human Disharmony Loop (central). by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 369
    Sample Pain Diagrams.

    Sample Pain Diagrams. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 370
    Patient Example.

    Patient Example. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 371
    ATGL-1 levels increase and lipid droplets decrease in response to <i>N. parisii</i> infection.

    ATGL-1 levels increase and lipid droplets decrease in response to <i>N. parisii</i> infection. by Hala Tamim El Jarkass (16625309)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 372
    Clinical diagnosis and abnormal signals of AEFIs(/10,000).

    Clinical diagnosis and abnormal signals of AEFIs(/10,000). by Chao Zhang (51048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 373
    Clinical prognosis analysis of other DE-ERSRGs except PDHB.

    Clinical prognosis analysis of other DE-ERSRGs except PDHB. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 374
    Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection.

    Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

    Published 2025
    Save to List
    Saved in:
  15. 375
    Synthesis and Preclinical Evaluation of Novel <sup>99m</sup>Tc-Labeled FR-Targeting Agents with Satisfactory Imaging Contrast and Reduced Renal Uptake

    Synthesis and Preclinical Evaluation of Novel <sup>99m</sup>Tc-Labeled FR-Targeting Agents with Satisfactory Imaging Contrast and Reduced Renal Uptake by Junhong Feng (11835903)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 376
    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. However, M:D FMT products exhibited the smallest median loss of bacterial viability following lyophilization and outperforms other lyopreservatives. Data is represented as median and range in parentheses. Significant p-values are bolded. Abbreviations: C, centrifuged; NC, not centrifuged; MD, maltodextrin and trehalose.

    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing.... by Nina K. Randolph (21030732)

    Published 2025
    “…Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. …”
    Save to List
    Saved in:
  17. 377
    ZLN005 and metformin cell toxicity.

    ZLN005 and metformin cell toxicity. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 378
    ZLN005 increases PGC-1α and TFAM expression.

    ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 379
    ZLN005 and metformin toxicity in MAC.

    ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 380
    Full Western blot images from manuscript.

    Full Western blot images from manuscript. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: